Evaluation of stroke incidence with duty ‐cycled multielectrode‐phased radiofrequency ablation of persistent atrial fibrillation results of the VICTORY AF Study
ConclusionsVICTORY AF demonstrated a 1.6% incidence of stroke in PersAF undergoing ablation with a phased RF system which did not meet statistical confidence due to poor enrollment. The secondary outcomes suggest comparable efficacy to phased RF in the tailored treatment of permanent AF trial. Rigorous clinical evaluation of the stroke risk of new AF ablation technologies as well as restriction to Vitamin K antagonist anticoagulation appears to be unachievable goals in a clinical multicenter IDE trial of AF ablation in the current era.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: John Hummel,
Atul Verma,
Hugh Calkins,
Lee H. Schwamm,
Daryl Gress,
Darryl Wells,
Joseph Souza,
Robert B. Hokanson,
Lauren Hemingway,
Kurt Stromberg,
Robert Hoyt,
Andrew Wickliffe,
David DeLurgio,
Lucas Boersma Tags: ORIGINAL ARTICLE Source Type: research
More News: Atrial Fibrillation | Brain | Cardiology | Cardiovascular | Coumadin | Heart | Heart Disease | Ischemic Stroke | Neurology | Statistics | Stroke | Study | Vitamin K | Vitamins | Warfarin